✦ LIBER ✦

Distribution and Antigenic Analysis of Circulating F(ab′)2-Reactive IgG in Patients with HIV-1 Infection

✍ Scribed by Franco Silvestris; Michela Di Loreto; Alessandra Romito; Maria A. Grizzuti; Franco Dammacco

Book ID: 112240568
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 370 KB
Volume: 73
Category: Article
ISSN: 1090-2341
DOI: 10.1006/clin.1994.1192

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Haplotype analysis of HLA-A, -B antigens

Haplotype analysis of HLA-A, -B antigens and -DRB1 alleles in south Indian HIV-1-infected patients with and without pulmonary tuberculosis

✍ S. Raghavan; P. Selvaraj; S. Swaminathan; K. Alagarasu; G. Narendran; P. R. Nara 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Efficacy and safety of darunavir-ritonav

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

✍ Bonaventura Clotet; Nicholas Bellos; Jean-Michel Molina; David Cooper; Jean-Chri 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 180 KB

FLOW CYTOMETRIC ANALYSIS OF THE TH1–TH2

FLOW CYTOMETRIC ANALYSIS OF THE TH1–TH2 BALANCE IN HEALTHY INDIVIDUALS AND PATIENTS INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) RECEIVING A PLANT STEROL/STEROLIN MIXTURE

✍ Ulrike Breytenbach; Anel Clark; Johan Lamprecht; Patrick Bouic 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 114 KB

## Abstract The Th1–Th2 balance plays a pivotal role in determining the outcome of an immune response to an infectious organism. It is proposed that during HIV infection, disease progression is characterized by a loss of Th1 activity, a shift to a more ‘allergic’ Th2‐type response and hence loss of

45 Comparative efficacy of HIV inhibitor

45 Comparative efficacy of HIV inhibitors on cells infected with cell free HIV or cocultivated with HIV-infected cells: L. Vrang1, C. Rydergard1, C. Ahgren1, P. Engelhardt1, M. Hogberg1, J. Kangasmetsa1, P. Lind1, R. Noreen1, C. Sahlberg1, X.-X. Zhou1, N. G. Johansson1, C. Lopez2, J. M. Morin, Jr.2, R. J. Ternansky2, F. W. Bell2, C. L. Jordan2, M. D. Kinnick2, J. A. Palkowitz2, C. A. Parrish2, P. Pranc2, R. T. Vasileff2, S. J. West2, and B. Oberg1. 1Medivir AB, Huddinge, Sweden; 2Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Interferon-α 2b treatment of chronic act

Interferon-α 2b treatment of chronic active hepatitis C in patients co-infected with the human immunodeficiency virus (HIV): HCV viremia quantified by B-DNA and genotypic analysis 1111221. Dept. of Gastroenterology1 and Hematology2, Hospital Geral de Santo António, Oporto, Portugal

📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB